Qrons Inc. Announces Launch of New Website Website Offers Visitors Insight Into the Company's Innovative Multi-Disciplinary Approach to Traumatic Brain Injuries

Qrons Inc. (OTCPK: QRON) (“Qrons ” or the “Company”), a preclinical biotechnology company developing advanced cell-based solutions to combat neuronal injuries with a laser focus on traumatic brain injuries, announced today the launch of its fully featured website. The website offers quick and easy access to essential information by offering a comprehensive understanding of the Company’s innovative [PR.com]

Pharmaceutical Stocks

[stock-ticker]

© 2017 Drugs News All rights reserved.       Privacy Policy       Contact Us